As Insmed INC (Put) (INSM) Shares Rose, Shareholder Sio Capital Management LLC Has Boosted Stake

December 8, 2017 - By Hazel Jackson

Investors sentiment increased to 1.76 in 2017 Q2. Its up 0.63, from 1.13 in 2017Q1. It improved, as 9 investors sold INSM shares while 25 reduced holdings. 24 funds opened positions while 36 raised stakes. 55.47 million shares or 1.68% less from 56.42 million shares in 2017Q1 were reported. Geode Cap Lc owns 0% invested in Insmed Incorporated (NASDAQ:INSM) for 531,151 shares. Hbk Investments Limited Partnership owns 31,100 shares for 0% of their portfolio. Blackrock, a New York-based fund reported 4.70 million shares. Wells Fargo Communication Mn holds 0% in Insmed Incorporated (NASDAQ:INSM) or 44,563 shares. Rhumbline Advisers has invested 0% in Insmed Incorporated (NASDAQ:INSM). Fincl Bank Of America Corp De stated it has 0% of its portfolio in Insmed Incorporated (NASDAQ:INSM). Td Asset has invested 0.01% of its portfolio in Insmed Incorporated (NASDAQ:INSM). Credit Suisse Ag has 0% invested in Insmed Incorporated (NASDAQ:INSM). Swiss National Bank & Trust reported 96,800 shares. Pictet Asset Mngmt Limited accumulated 131,143 shares. Qs Invsts Ltd Liability Corp, New York-based fund reported 73,262 shares. Tiaa Cref Invest Management Limited reported 213,525 shares. Bank & Trust Of Montreal Can holds 0% of its portfolio in Insmed Incorporated (NASDAQ:INSM) for 659 shares. 202,443 were accumulated by Principal Gp. Bnp Paribas Arbitrage owns 7,498 shares for 0% of their portfolio.

Sio Capital Management Llc increased its stake in Insmed Inc (Put) (INSM) by 213.65% based on its latest 2017Q2 regulatory filing with the SEC. Sio Capital Management Llc bought 181,600 shares as the company’s stock rose 11.02% with the market. The institutional investor held 266,600 shares of the health care company at the end of 2017Q2, valued at $4.58 million, up from 85,000 at the end of the previous reported quarter. Sio Capital Management Llc who had been investing in Insmed Inc (Put) for a number of months, seems to be bullish on the $2.21 billion market cap company. The stock increased 2.81% or $0.79 during the last trading session, reaching $28.87. About 574,045 shares traded. Insmed Incorporated (NASDAQ:INSM) has risen 57.88% since December 8, 2016 and is uptrending. It has outperformed by 41.18% the S&P500.

Sio Capital Management Llc, which manages about $116.75 million and $210.44M US Long portfolio, decreased its stake in Acorda Therapeutics Inc (Put) (NASDAQ:ACOR) by 665,400 shares to 380,000 shares, valued at $7.49M in 2017Q2, according to the filing. It also reduced its holding in Koninklijke Philips Nv (Call) (NYSE:PHG) by 235,286 shares in the quarter, leaving it with 8,900 shares, and cut its stake in Sage Therapeutics Inc (Put) (NASDAQ:SAGE).

More recent Insmed Incorporated (NASDAQ:INSM) news were published by: which released: “Insmed Announces Positive Top-Line Results from Phase 3 CONVERT Study of ALIS …” on September 05, 2017. Also published the news titled: “Insmed to Host Analyst and Investor Day on July 19, 2017” on July 12, 2017.‘s news article titled: “Insmed to Present at Two November Conferences” with publication date: November 08, 2017 was also an interesting one.

Insmed Incorporated (NASDAQ:INSM) Ratings Coverage

Among 10 analysts covering Insmed (NASDAQ:INSM), 8 have Buy rating, 0 Sell and 2 Hold. Therefore 80% are positive. Insmed had 22 analyst reports since August 10, 2015 according to SRatingsIntel. The firm has “Buy” rating by H.C. Wainwright given on Monday, November 6. Robert W. Baird initiated Insmed Incorporated (NASDAQ:INSM) on Monday, July 10 with “Buy” rating. The firm has “Buy” rating given on Thursday, November 2 by Stifel Nicolaus. The company was maintained on Monday, September 11 by Cowen & Co. The rating was maintained by Citigroup with “Neutral” on Wednesday, March 16. Cowen & Co maintained the shares of INSM in report on Thursday, July 20 with “Buy” rating. Stifel Nicolaus initiated Insmed Incorporated (NASDAQ:INSM) on Tuesday, March 15 with “Buy” rating. On Tuesday, October 6 the stock rating was maintained by H.C. Wainwright with “Buy”. The stock of Insmed Incorporated (NASDAQ:INSM) earned “Neutral” rating by UBS on Monday, November 9. Zacks downgraded the shares of INSM in report on Monday, August 10 to “Hold” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.